Vulnerability Description
OpenClinic GA versions 5.09.02 and 5.89.05b contain an authentication mechanism within the system that does not provide sufficient complexity to protect against brute force attacks, which may allow unauthorized users to access the system after no more than a fixed maximum number of attempts.
CVSS Score
CRITICAL
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Openclinic Ga Project | Openclinic Ga | 5.09.02 |
Related Weaknesses (CWE)
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-184-01Third Party AdvisoryUS Government Resource
- https://us-cert.cisa.gov/ics/advisories/icsma-20-184-01Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2020-14494?
CVE-2020-14494 is a vulnerability with a CVSS score of 9.8 (CRITICAL). OpenClinic GA versions 5.09.02 and 5.89.05b contain an authentication mechanism within the system that does not provide sufficient complexity to protect against brute force attacks, which may allow un...
How severe is CVE-2020-14494?
CVE-2020-14494 has been rated CRITICAL with a CVSS base score of 9.8/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2020-14494?
Check the references section above for vendor advisories and patch information. Affected products include: Openclinic Ga Project Openclinic Ga.